Join Fox News for access to this content Plus special access to select articles and other premium content with your account – free of charge. Please enter a valid email address. By entering your email and pushing continue, you are agreeing to
Neurotech company Parasym has developed a groundbreaking neuromodulation device, Nurosym, that may finally bring hope to providing treatment for patients diagnosed with Long COVID. In an exclusive interview with the Express, Nathan Dundovic, co-founder of Parasym, explained: “Nurosym works by placing an
A new CDC report estimates that the number of U.S. adults with chronic fatigue syndrome is approximately 3.3 million. The CDC’s estimate is larger than previous studies, which health officials say is influenced by long COVID patients. The cause is unknown, but
The first-ever drug generated by artificial intelligence has entered Phase 2 clinical trials, with the first dose successfully administered to a human, Insilico Medicine announced yesterday. The drug, currently referred to as INS018_055, is being tested to treat idiopathic pulmonary fibrosis (IPF),
Millennials are seeking more professional help for health issues than ever, a new study revealed. Conducted by United Healthcare and Health Action Council, the study explored factors and claims data from policyholders ages 27 to 42 — a total of 126,000 individuals.
Renters in London may have to move further out of the capital due to shortage of rental options, said the boss of London’s biggest estate agent. Foxtons chief executive Guy Gittins said that people who are being priced out will “have to